PSMA PET-CT scan for men on prostate cancer surveillance
Part of Cancer, Kidney & urinary clinical trials.
This study checks whether a special prostate scan called PSMA PET-CT (along with standard monitoring scans) can help guide care while you are on “active surveillance” instead of immediate treatment. It may help doctors track low-risk prostate cancer changes more accurately over time.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a man age 18 or older.
- Your prostate cancer diagnosis is “low risk” or “favorable intermediate risk” based on specific pathology details (including limits on tumor involvement and no certain aggressive patterns).
- Your PSA blood test is under 20.
- You can get yearly PSMA PET-CT and yearly prostate mpMRI scans.
- You can have yearly prostate biopsies using a transrectal or transperineal template/fusion biopsy approach.
- You have not had prior prostate cancer treatment and have not used prostate cancer systemic therapy.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new imaging test called rhPSMA-7.3 (18F) PET/CT to see if it can better detect prostate cancer in men who are on active surveillance because their cancer is considered low-risk or favorable intermediate-risk. You would also get an MRI and a biopsy as part of the study.
This Phase 3 study checks whether a PSMA PET/CT scan (using a special tracer) can help doctors make better decisions for people with prostate cancer after treatment, based on PSA blood test changes. It may help identify whether cancer has spread or how to plan next steps.
This trial looks at using a PSMA PET/CT scan to better re-check cancer activity in men whose PSA has started rising after prostate removal. If you qualify, the scan may help doctors choose the next best treatment step.
This study tests whether using a special PET scan (PSMA PET/CT) to guide prostate biopsy can help find cancer more accurately and in real time. It might help men who need a biopsy because of high PSA levels or abnormal MRI results.
This study tests whether a special PET scan (PSMA PET) can better detect prostate cancer in men whose MRI results are unclear. If it works, it may help avoid unnecessary biopsies or find cancer sooner.
This study uses a special type of PET scan called PSMA PET to better understand and track prostate cancer. The scan helps doctors see where the cancer is in the body and if treatment is working.
Hear when a new Prostate cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.